Federal Spending on Off-Patent Drugs That Lack Generic Competition

被引：5
作者：
Rome, Benjamin N. [1 ,2 ]
Kesselheim, Aaron S. [1 ,2 ]
机构：
[1] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law PORTAL, 75 Francis St, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
来源：
JOURNAL OF GENERAL INTERNAL MEDICINE | 2021年 / 36卷 / 03期
关键词：
D O I：
10.1007/s11606-020-05752-y
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：821 / 823
页数：3
相关论文
共 50 条
  • [41] Evaluating the benefits of TNF-alfa inhibitor biosimilar competition on off-patent and on-patent drug markets: A Southern European analysis
    Barcina Lacosta, Teresa
    Vulto, Arnold G.
    Huys, Isabelle
    Simoens, Steven
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [42] Governments, off-patent vaccines, smallpox and universal childhood vaccination
    Music, Stanley
    VACCINE, 2010, 28 (04) : 869 - 872
  • [43] THE IMPACT OF REGIONAL LEGISLATIVE MEASURES ON THE PRESCRIPTION OF OFF-PATENT MEDICINES
    Tettamanti, A.
    Urbinati, D.
    Tucci, C.
    VALUE IN HEALTH, 2016, 19 (07) : A446 - A446
  • [44] MARKET UPTAKE MODELS OF BIOSIMILARS AND OFF-PATENT BIOLOGICAL MEDICINES
    Moorkens, E.
    Meuwissen, N.
    Huys, I
    Vulto, A.
    Declerck, P.
    Simoens, S.
    VALUE IN HEALTH, 2016, 19 (07) : A452 - A452
  • [45] Policy options for sustainable access to off-patent antibiotics in Europe
    Dimitra Panteli
    Michael Anderson
    Thomas Fieldman
    Enrico Baraldi
    Thomas Tängdén
    Sabine Vogler
    Christine Årdal
    Elias Mossialos
    npj Antimicrobials and Resistance, 2 (1):
  • [46] Characteristics and Price Increases Among Sole-Source, Off-Patent Drugs in the United States, 2008 to 2018
    Alpern, Jonathan D.
    Shahriar, Arman A.
    Xi, Min
    Thapa, Sunita
    Kodet, Amy J.
    Stauffer, William M.
    Benitez, Gabriela Vazquez
    Pawloski, Pamala A.
    Dehmer, Steven P.
    JAMA NETWORK OPEN, 2020, 3 (08) : E2013595
  • [47] Affordability and availability of off-patent drugs in the United States-the case for importing from abroad: observational study
    Gupta, Ravi
    Bollyky, Thomas J.
    Cohen, Matthew
    Ross, Joseph S.
    Kesselheim, Aaron S.
    BMJ-BRITISH MEDICAL JOURNAL, 2018, 360
  • [48] Off-Patent Biological and Biosimilar Medicines in Belgium: A Market Landscape Analysis
    Vandenplas, Yannick
    Simoens, Steven
    Van Wilder, Philippe
    Vulto, Arnold G.
    Huys, Isabelle
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [49] OFF-PATENT BRAND ANTIDEPRESSANTS UTILIZATION: A NATIONALLY REPRESENTATIVE SAMPLE ANALYSIS
    Alruthia, Y. S.
    VALUE IN HEALTH, 2013, 16 (03) : A66 - A66
  • [50] Leukemia Society decries lack of federal spending
    不详
    ONCOLOGY-NEW YORK, 1999, 13 (04): : 446 - 446
12345